Collateral for a security interest recorded Jun 26, 2024 (Exeltis USA, Inc.).
Term ends Nov 2, 2032 · High confidence
20-year base term ends Nov 2, 2032
Held by Agile Therapeutics, Inc.
Filed Nov 2, 2012 as application 13/667,632 · Granted Jun 14, 2016
Base term, 20 years from filing
Today
2012
2032
Clock starts
Nov 2, 2012
Nov 2, 2012
Term ends
Nov 2, 2032
Nov 2, 2032
Granted
Jun 14, 2016
Jun 14, 2016
base term
fee events
Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
None
Terminal disclaimer
No disclaimer on this record.
2 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
66
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.
This patent's term is its 20-year base term, with no adjustment for prosecution delay. 2 of 3 maintenance fees are paid so far. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Nov 2, 2012, when this application, 13/667,632, was filed | Nov 2, 2032 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 2 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Nov 2, 2032 | High confidence |
Partial family
| Application PCT/US2000/032043 | PCT application no patent term | no patent term |
| US 7,045,145 | Term ended Mar 2021 | Mar 2021 |
| US 7,384,650 | Term ended Mar 2021 | Mar 2021 |
| Application PCT/US2004/023246 | PCT application no patent term | no patent term |
| Application 11/601,954 | Abandoned not computed | not computed |
| Application PCT/US2008/069618 | PCT application no patent term | no patent term |
| Application PCT/US2008/069622 | PCT application no patent term | no patent term |
| Application 61/103,705 | Pending not computed | not computed |
8 of 66 applications in this family shown, earliest filings first. Partial: 1 of the 66 has no file history here, so its row comes from the patent's own record or names the application alone. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Nov 16, 2012 Reel 29315, frame 914 | Arnold, Charles G.; Kydonieus, Agis; Rossi, Thomas M.; Altomari, Alfred F. | Agile Therapeutics, Inc. | Assignment of Assignor's Interest |
| Feb 12, 2020 Reel 51792, frame 453 | Agile Therapeutics, Inc. | Perceptive Credit Holdings III, LP | Security Interest |
| Apr 24, 2024 Reel 67204, frame 103 | Perceptive Credit Holdings III, LP, as Administrative Agent | Agile Therapeutics, Inc. | Release of Security Interests in Patents and Trademarks |
| Jun 26, 2024 Reel 67846, frame 890 | Agile Therapeutics, Inc. | Exeltis USA, Inc. | Security Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Nov 2032
Term ends Nov 2, 2032. Maintenance fees still fall due before then
Citations
53
later US patents cite this one
That is top 10% of utility patents granted in 2016 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.